The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
With recent federal actions to curtail vaccine access, many states have announced actions intended to maintain broader access. This issue brief provides a snapshot of this rapidly changing landscape, tracking which states have instituted changes in response to or in anticipation of administration policy changes.
Total spending among traditional Medicare beneficiaries fell in 2020, the first year of the COVID-19 pandemic, corresponding to lower service use across most types of Medicare-covered health care services compared to 2019. The lower spending in traditional Medicare contributed to the relatively slower growth in Medicare spending overall in 2020.
This fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (ella), intrauterine devices (copper IUDs and levonorgestrel IUDs), and progestin-based pills (Plan B and Next Choice).
This issue brief describes how state Medicaid programs are implementing arrangements aimed at coordinating Medicare and Medicaid for dual-eligible individuals.
A new KFF analysis finds about 1 in 20 privately insured people (5.7%) received at least one ACA preventive service or drug that could be affected by a now-stayed U.S. District Court ruling in Braidwood Management v. Becerra, which found the Affordable Care Act’s (ACA) preventive services mandate partially unconstitutional. The district court also found that pre-exposure prophylaxis (PrEP), medication recommended for HIV prevention, violates the religious rights of those who have objections to its…
In this column for the JAMA Forum, KFF's Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.
With lowering prescription drug costs a top priority for Americans, the Trump Administration, presidential candidates, members of Congress, and several states are proposing to allow the importation of drugs from abroad, chiefly Canada. The idea of allowing drugs to be imported from Canada and other countries is popular with Americans across the political spectrum, but has yet to be implemented due to concerns about safety, and strong opposition from the drug industry. A new KFF…
This report presents findings from the 2022 KFF Women’s Health Survey (WHS) on women’s health status, use of health care services, and costs. The WHS is a nationally representative survey of 5,145 self-identified women ages 18 to 64, conducted May 10 - June 7, 2022.
In this brief, we explore avenues for expanding hormonal contraceptive care and supplies through pharmacies, as well as how and where pharmacies and pharmacists may be positioned to fill gaps in contraceptive care where there are few brick-and-mortar family planning providers, as well as the challenges in expanding these pathways.
KFF examines how many Medicaid enrollees used Long-Term Services and Supports (LTSS) for aging, illness, or disability in 2020, how much Medicaid spent on these enrollees, and policy issues to watch in the coming years.
© 2026 KFF